Predicting treatment response in non-Hodgkin’s lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine1
- 1 April 2004
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 11 (4), 368-376
- https://doi.org/10.1016/s1076-6332(03)00721-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Aggressive Non-Hodgkin Lymphoma: Early Prediction of Outcome with67Ga ScintigraphyRadiology, 2000
- 18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CTLeukemia & Lymphoma, 2000
- CD44 expression predicts disease outcome in localized large B cell lymphomaLeukemia, 1999
- Prognostic relevance of apoptotic cell death in non‐Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expressionHistopathology, 1998
- Prognostic Implications of Proliferating Cell Nuclear Antigen (PCNA), AgNORs and P53 in Non-Hodgkin's LymphomasLeukemia & Lymphoma, 1998
- CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factorBlood, 1995
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Peripheral T-cell lymphomas: A clinicopathologic study of 75 casesHuman Pathology, 1990
- Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67Blood, 1988